Immunity boost: Some people with ‘lucky genes’ may get an extra strong protection from COVID shots

antibodies can provided added immunity boost
Credit: ABC News

Some people with “lucky genes” or certain DNA may get extra strong protection after Covid jabs, say scientists from University of Oxford.

The researchers found people with a version of a gene called HLA-DQB1*06 had a bigger antibody response following vaccination than others.

About 30 to 40% of the UK population have this type.

The preliminary work appears in Nature Medicine. More research is needed to confirm it.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Researchers analysed blood samples from people who took part in five different trials, including 1,600 adults who had either the Oxford-AstraZeneca or Pfizer-BioNTech vaccine as their first jab.

They found people who carried the gene variant were more likely to have higher levels of antibodies – proteins that recognise and attack coronavirus – a month after their first jab than people who had other versions of the gene.

The study also followed a group of people who had weekly Covid tests for more than a year after their first jab.

They found those who had the gene variant were less likely to experience a “breakthrough infection” over this time period, where people still got a mild Covid infection after vaccination.

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.